201 related articles for article (PubMed ID: 6121091)
1. Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy.
Burns WH; Saral R; Santos GW; Laskin OL; Lietman PS; McLaren C; Barry DW
Lancet; 1982 Feb; 1(8269):421-3. PubMed ID: 6121091
[TBL] [Abstract][Full Text] [Related]
2. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
Field HJ; Larder BA; Darby G
Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
[TBL] [Abstract][Full Text] [Related]
4. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.
Wade JC; McLaren C; Meyers JD
J Infect Dis; 1983 Dec; 148(6):1077-82. PubMed ID: 6317768
[TBL] [Abstract][Full Text] [Related]
5. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
[No Abstract] [Full Text] [Related]
6. Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient.
Christophers J; Sutton RN
J Antimicrob Chemother; 1987 Sep; 20(3):389-98. PubMed ID: 2824424
[TBL] [Abstract][Full Text] [Related]
7. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
Sibrack CD; McLaren C; Barry DW
Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
[TBL] [Abstract][Full Text] [Related]
8. Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infections.
Chou S; Gallagher JG; Merigan TC
Lancet; 1981 Jun; 1(8235):1392-4. PubMed ID: 6113353
[TBL] [Abstract][Full Text] [Related]
9. Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients.
Mitchell CD; Bean B; Gentry SR; Groth KE; Boen JR; Balfour HH
Lancet; 1981 Jun; 1(8235):1389-92. PubMed ID: 6113352
[TBL] [Abstract][Full Text] [Related]
10. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
Field HJ; Neden J
Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
[TBL] [Abstract][Full Text] [Related]
11. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.
Shepp DH; Newton BA; Dandliker PS; Flournoy N; Meyers JD
Ann Intern Med; 1985 Jun; 102(6):783-5. PubMed ID: 2986508
[TBL] [Abstract][Full Text] [Related]
12. Strategies of drug resistance in herpes simplex.
Field HJ; Darby GK
Nature; 1980 Aug; 286(5776):842. PubMed ID: 6251373
[No Abstract] [Full Text] [Related]
13. [Resistance of herpes simplex viruses to antiviral drugs].
Scieux C; Bianchi A
Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
[TBL] [Abstract][Full Text] [Related]
14. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus.
Field HJ; Darby G; Wildy P
J Gen Virol; 1980 Jul; 49(1):115-24. PubMed ID: 6252285
[TBL] [Abstract][Full Text] [Related]
16. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.
Darby G; Field HJ; Salisbury SA
Nature; 1981 Jan; 289(5793):81-3. PubMed ID: 6256650
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
O'Brien WJ; Taylor JL
Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
[No Abstract] [Full Text] [Related]
20. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
de Clercq E
Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
